In a parallel line of inquiry, acanthoic acid activated FXR and LXRs, suggesting the FXR-LXR axis is an effective target for NAFLD (Han et al., 2019). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.